Cytopenias

Sharing on behalf of Dr. Kim Nichols,

Dear NICER colleagues, In collaboration with the North American Consortium for Histiocytosis (NACHO), Melissa Hines and I are running a clinical trial investigating the efficacy and tolerability of a response-adapted ruxolitinib-containing regimen for children with newly diagnosed or relapsed/refractory HLH. The protocol is now open at 10 participating sites, including:

• St. Jude Children’s Research Hospital – Memphis, TN

• Children’s Hospital of Philadelphia – Philadelphia, PA

• UCSF Benoiff Children’s Hospital – San Francisco, CA

• Children’s Hospital of Orange County – Orange , CA